City Therapeutics Inc. logo

City Therapeutics Inc.

CTY | NASDAQ
Chart Builder DCF Calculator
$21.04
+$0.33 (+1.59%)
Nov 2, 2026, 2:10 PM ET · Market open
TTM
Period Ending
Q2 2020
Jun 30, 2020
Q1 2020
Mar 31, 2020
Q4 2019
Dec 31, 2019
Q3 2019
Sep 30, 2019
Q2 2019
Jun 30, 2019
Q1 2019
Mar 31, 2019
Q4 2018
Dec 31, 2018
Q3 2018
Sep 30, 2018
Q2 2018
Jun 30, 2018
Q1 2018
Mar 31, 2018
Q4 2017
Dec 31, 2017
Q3 2017
Sep 30, 2017
Q2 2017
Jun 30, 2017
Q1 2017
Mar 31, 2017
Q4 2016
Dec 31, 2016
Q3 2016
Sep 30, 2016
Q2 2016
Jun 30, 2016
Q1 2016
Mar 31, 2016
Q4 2015
Dec 31, 2015
Q3 2015
Sep 30, 2015
Q2 2015
Jun 30, 2015
Q1 2015
Mar 31, 2015
Revenue
6.49B 8.02B 8.16B 8.26B 8.37B 8.42B 8.49B 8.49B 8.49B 8.52B 8.55B 8.64B 8.73B 8.82B 8.91B 8.94B 9B 9B 8.96B 8.95B 8.86B 8.84B
Cost of Revenue
2.21B 2.3B 2.44B 2.49B 2.55B 2.67B 2.77B 2.8B 2.85B 2.87B 2.88B 2.92B 2.94B 2.95B 2.93B 2.9B 2.88B 2.89B 2.87B 2.95B 2.92B 2.87B
Gross Profit
4.29B 5.72B 5.72B 5.77B 5.82B 5.75B 5.73B 5.69B 5.64B 5.65B 5.67B 5.72B 5.79B 5.87B 5.98B 6.04B 6.13B 6.11B 6.09B 6B 5.94B 5.97B
Operating Income
2.83B 2.9B 2.88B 2.94B 2.91B 2.79B 2.66B 2.58B 2.42B 2.37B 2.31B 2.23B 2.25B 2.28B 2.32B 2.43B 2.42B 2.34B 2.26B 2.13B 2.09B 2.12B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
2.43B 2.49B 2.47B 2.52B 2.44B 2.31B 2.16B 2.05B 1.92B 1.85B 1.79B 1.71B 1.69B 1.72B 1.76B 1.86B 1.89B 1.81B 1.73B 1.62B 1.58B 1.61B
Net Income
1.8B 1.84B 1.83B 1.85B 1.82B 1.77B 1.67B 2.11B 1.92B 1.76B 1.66B 1.05B 1.04B 1.06B 1.09B 1.17B 1.18B 1.13B 1.07B 969M 946M 964M
Selling & General & Admin
-1.66B -493M 659M 5.32B 5.46B 5.63B 5.83B 5.92B 6.07B 6.15B 6.24B 6.41B 6.48B 6.54B 6.59B 6.52B 6.58B 6.66B 6.7B 6.82B 6.77B 6.73B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
-1.66B -493M 659M 5.32B 5.46B 5.63B 5.83B 5.92B 6.07B 6.15B 6.24B 6.41B 6.48B 6.54B 6.59B 6.52B 6.58B 6.66B 6.7B 6.82B 6.77B 6.73B
Interest Expense
-191M -95M n/a 384M 401M 425M 448M 467M 472M 469M 465M 464M 468M 471M 478M 479M 477M 476M 473M 473M 469M 466M
Selling & Marketing Expenses
1.16B 2.3B 3.44B 4.67B 4.77B 4.89B 5.03B 5.1B 5.19B 5.26B 5.31B 5.4B 5.47B 5.53B 5.57B 5.58B 5.61B 5.67B 5.69B 5.77B 5.72B 5.66B
Cost & Expenses
5.57B 6.34B 7.1B 7.8B 8.01B 8.3B 8.6B 8.72B 8.92B 9.02B 9.12B 9.34B 9.42B 9.49B 9.52B 9.41B 9.46B 9.55B 9.58B 9.77B 9.69B 9.6B
Income Tax Expense
633M 647M 641M 676M 621M 535M 494M -56M 1M 90M 134M 664M 655M 664M 678M 695M 707M 680M 659M 651M 636M 646M
Shares Outstanding (Basic)
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Diluted)
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EPS (Basic)
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EPS (Diluted)
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA
3.58B 3.75B 3.83B 4.28B 4.23B 4.15B 4.04B 4B 3.91B 3.87B 3.84B 3.78B 3.79B 3.85B 3.92B 4.06B 4.13B 4.09B 4.05B 3.97B 3.96B 4.01B
EBIT
975M 1.72B 2.47B 2.91B 2.84B 2.73B 2.61B 2.52B 2.39B 2.32B 2.26B 2.18B 2.16B 2.19B 2.24B 2.34B 2.37B 2.29B 2.21B 2.09B 2.05B 2.08B
Depreciation & Amortization
1.35B 1.36B 1.36B 1.37B 1.39B 1.41B 1.44B 1.48B 1.52B 1.55B 1.58B 1.6B 1.63B 1.65B 1.68B 1.72B 1.76B 1.8B 1.84B 1.88B 1.91B 1.94B

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.